research 8 research posters presented by Prime at the 2024 AMCP Annual Meeting Prime remains at the forefront of researching real-world drug utilization, managed care pharmacy programs, and costs...

AMCP Annual Meeting 2025 research posters Studies include Prime’s GLP-1 obesity research and a Medicare drug cost predictive model Click on the poster image to view the full-size version. Prime...

Help lower costs with biosimilars We actively promote evidence-based use of biosimilars to help you make the most of your integrated drug strategy. Breadcrumb Home Our solutions Condition...

publications Weight management: A holistic journey May 1, 2024 Obesity is a global epidemic and major public health issue that has grown in prevalence over recent decades in adults, adolescents...

Expert Clinical Network Insights Hemophilia December 17, 2024 Medication insights: marstacimab-hncq (Hympavzi) The U.S. Food and Drug Administration (FDA) approved marstacimab-hncq (Hympavzi) in...

publications Drug Approvals: July 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches July 31, 2024 Specialty New drugs Jun. 20,...

PUBLICATIONS FDA Decisions Expected: February 2025 Drug pipeline for February 2025 January 15, 2025 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we...

PUBLICATIONS FDA Decisions Expected: May 2025 Your monthly synopsis of new drugs expected to hit the market April 14, 2025 Drug pipeline for May 2025 At Prime Therapeutics (Prime), we have...